Section Arrow
VTVT.NASDAQ
- vTv Therapeutics
Quotes are at least 15-min delayed:2024/12/23 22:12 EST
Last
 13.87
-1.09 (-7.29%)
Day High 
14.7999 
Prev. Close
14.96 
1-M High
18.37 
Volume 
11.63K 
Bid
11.37
Ask
14.61
Day Low
13.75 
Open
14.66 
1-M Low
14.04 
Market Cap 
39.08M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 15.69 
20-SMA 15.76 
50-SMA 15 
52-W High 30.99 
52-W Low 7.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.37/-4.85
Enterprise Value
39.25M
Balance Sheet
Book Value Per Share
5.75
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.4031-0.2085-34.09%-- 
RAPTRAPT Therapeutics1.74+0.9146+110.81%-- 
TRAWTraws Pharma Inc12.57+7.55+150.40%-- 
CEROCERo Therapeutics Holdings0.0505-0.0056-9.98%-- 
RXRXRecursion Pharmaceuticals6.99+0.96+15.92%-- 
Quotes are at least 15-min delayed:2024/12/23 22:12 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.